Page 30 - Avoid Food and Drug Interactions

Vascular Access Selection
and Management

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. Vascular Access for PN Administration

• Placement of central venous access devices (CVAD) associated with
adverse events, even in the absence of PN1

• CLABSI associated with prolonged hospital LOS and higher cost of
hospitalization1,2

o Median estimated cost savings per one prevented CLABSI: $42,609 (IQR
19,000–46,739)2

• Use of “care bundles” has been associated with sustained reduction in
rate of CLABSI1,2,3

1. O’Grady NP. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39;S1-S34.
2. Ista E. Lancet Infect Dis 2016;16: 724–34

3. Marschall. Strategies to prevent central line-associated bloodstream infections in acute care hospitals:2014 update. Infect

Control Hosp Epidemiol.2014;35(7):753-771.

56

30